このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

The Geniohyoid Muscle in Critical Illness

2026年5月22日 更新者:Peter Turton、Warrington Hospital

Assessing the Feasibility and Reliability of an Ultrasound-based Method of Measuring the Geniohyoid Muscle in Mechanically Ventilated Patients - an Observational Study

Many patients lose muscle due to being unwell in an intensive care unit. This muscle loss can lead to weakness of the arms and legs when they leave the unit, and when they go home. For many years investigators have measured the size of these arm and leg muscles using an ultrasound machine, to take a picture of the muscles.

It is also known that patients who are on a ventilator (or "breathing machine") often have problems swallowing when the breathing tube is removed from their mouth. This may be because the muscles of swallowing may also shrink. One of these muscles sits under the jaw and can be measured with ultrasound - the method has been shown to be accurate and reliable in awake volunteers, but these volunteers are usually sat upright in a chair with their mouth closed.

Before it can be assed whether these muscles get smaller, it is needed to assess whether the chosen method is suitable in patients on a ventilator; these patients are lying in bed, and their mouths are open slightly due to the breathing tube.

Proposed Method

This investigation will measure the size of a muscle under the jaw (called the geniohyoid muscle) in patients who are sedated and have a breathing tube in their mouth connected to a ventilator.

Using a normal hospital ultrasound machine, one researcher will place the ultrasound probe under the patient's jaw. When the researcher is happy the probe is in the right place, they will take a picture of the muscle and measure its size and thickness. After a short break, the researcher will repeat this process. After a second short break, another researcher who did not watch the first researcher will also place the probe under the jaw and take a picture of the muscle.

These measurements can be used to to answer the following questions:

  1. How many patients scanned produced images that could be measured?
  2. How consistent are the measurements if one person measures the same muscle twice?
  3. If two people measure the same muscle, do their measurements agree with each other?

The patients will be under sedation when they take part in the study. Because of this, they cannot consent to take part in the study. The patient's next of kin or carer would advise on whether the patient would want to take part. When the patient is awake and has the breathing tube removed, the research team would ask them to sign a consent form to use their data.

調査の概要

状態

まだ募集していません

条件

詳細な説明

Introduction

Many patients who are mechanically ventilated due to critical illness have difficulty in swallowing after the endotracheal tube is removed, a phenomenon known as Post Extubation Dsyphagia (PED). Although multifactorial, atrophy of the swallowing muscles is a potential cause.

Ultrasound is a commonly used investigative modality for the measurement of muscles in critically unwell patients. Measurements can be performed repeatedly over time to track changes in muscle size during the course of a patient's admission. In critically unwell patients, much of the research is focussed on muscles of the limbs and trunk. The muscles of swallowing have been measured using ultrasound, but in awake patients adopting an optimal seated position. Critically unwell patients are bedbound, and the endotracheal tube leaves their mouth in an open position. Before embarking on a study using ultrasound to attempt to track changes in muscle size in the muscles of swallowing, the investigators first wish to assess if such a method is both feasible and reliable.

Methods

Critically unwell patients who are sedated and mechanically ventilated will be recruited into the study after discussion with a patient's personal consultee. The geniohyoid (GH) muscle will be scanned in both the coronal and sagittal planes. The patient will be scanned three times. Twice by one assessor, and once by a second assessor. Cross sectional areas (CSA) of GH will be measured at a later time using image processing software (ImageJ, NIH, USA). Echogenicity, a measurement of the brightness of muscle on ultrasound, will also be assessed.

Results

The primary outcome is to obtain the proportion of patients whose images from ultrasound can provide satisfactory measurement data, in each plane. Furthermore, we will assess the repeatability of each measurement by calculating the intra-rater agreement, and the inter-rater agreement to assess agreement between assessors. An estimate of the mean CSA in each plane will be calculated.

Conclusions

This preliminary data will give us an estimate of the proportion of patients who can provide satisfactory images of GH, in preparation for a larger study assessing longitudinal changes in CSA. Further, the study will give data on both the inter- and intra-rather agreement of the method.

研究の種類

観察的

入学 (推定)

30

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

      • Warrington、イギリス、WA5 1QG
        • Intensive Care Unit
        • コンタクト:
          • Peter Turton, MBChB (Hons) MPhil FRCA FFICM
          • 電話番号:5594 01925 635911
          • メール:peter.turton1@nhs.net

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 大人
  • 高齢者

健康ボランティアの受け入れ

いいえ

サンプリング方法

非確率サンプル

調査対象母集団

Mechanically ventilated patients via an endotracheal tube who are admitted to the Intensive Care Unit of Warrington Hospital (North Cheshire and Mersey NHS Foundation Trust), at any time of their admission.

説明

Inclusion Criteria:

  • · Mechanically ventilated patient on the intensive care unit

    • Endotracheal tube via the mouth in-situ (size 7.0 and above)
    • Can be recruited at any time during their admission

Exclusion Criteria:

  • · Ventilated via a nasal endotracheal tube

    • Ventilated via a tracheostomy
    • Ventilated via a micro-endotracheal tube
    • Any previous or active history of head and neck cancer
    • Any previous head and neck surgery (excluding tonsillectomy and adenoidectomy)
    • Any cranio-facial deformity that would render access to the jaw difficult, including but not limited to short thymo-mental distance
    • Any neuromuscular disorder, including previous stroke
    • Any previous history of dysphagia or swallowing disorder
    • Pregnant patients
    • Patients under 18 years of age
    • Agitation or movement that would make measurement difficult or inaccurate

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

コホートと介入

グループ/コホート
Mechanically ventilated patient group
Any eligible patient who is being mechanically ventilated in the site's intensive care unit, via an endotracheal tube.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Satisfactory image acquisition of the geniohyoid muscle in the coronal plane (n, proportion)
時間枠:Day 1 (patients are only on the day of the ultrasound)
To obtain an estimate for the proportion of patients in which satisfactory images can be measured, in both measured planes (coronal and sagittal views). An "unsatisfactory" image is due to either the investigator being unable to adequately visualise the GH muscle with the probe (e.g. due to subcutaneous fat, difficult patient positioning, or when an image has been obtained, the offline CSA measurement cannot be performed due to inadequate visualisation of the muscle's fascial border. In addition, the co-efficient of variance of the three images taken must be less than 5%.
Day 1 (patients are only on the day of the ultrasound)
Satisfactory image acquisition of the geniohyoid muscle, sagittal plane (n, proportion)
時間枠:Day 1 - patients are only in the study on the day of the ultrasound scan
To obtain an estimate for the proportion of patients in which satisfactory images can be measured, in the sagittal plane. An "unsatisfactory" image is due to either the investigator being unable to adequately visualise the GH muscle with the probe (e.g. due to subcutaneous fat, difficult patient positioning, or when an image has been obtained, the offline CSA measurement cannot be performed due to inadequate visualisation of the muscle's fascial border. In addition, the co-efficient of variance of the three images taken must be less than 5%.
Day 1 - patients are only in the study on the day of the ultrasound scan

二次結果の測定

結果測定
メジャーの説明
時間枠
Intra-rater agreement, cross sectional area of geniohyoid muscle, coronal plane
時間枠:Day 1
In this outcome, investigator A will take 3 images (set A) of the geniohyoid muscle in the coronal plane. After a short break, a second set of 3 images (set B) will be taken. Intra-rater agreement will be assessed by comparing mean and standard deviation of both set A and B, and calculating the intra-class correlation co-efficient for consistency.
Day 1
Intra-rater agreement, cross sectional area of geniohyoid muscle, sagittal plane
時間枠:Day 1
In this outcome, investigator A will take 3 images (set A) of the geniohyoid muscle in the sagittal plane. After a short break, a second set of 3 images (set B) will be taken. Intra-rater agreement will be assessed by comparing mean and standard deviation of both set A and B, and calculating the intra-class correlation co-efficient for consistency.
Day 1
Inter-rater agreement, cross sectional area of geniohyoid muscle, coronal plane
時間枠:Day 1
In this outcome, investigator A will take 3 images (set A) of the geniohyoid muscle in the coronal plane. After a short break, investigator B will take a second set of 3 images (set C) Intra-rater agreement will be assessed by comparing mean and standard deviation of both set A and C, and calculating the intra-class correlation co-efficient for agreement.
Day 1
Inter-rater agreement, cross sectional area of geniohyoid muscle, sagittal plane
時間枠:Day 1
In this outcome, investigator A will take 3 images (set A) of the geniohyoid muscle in the coronal plane. After a short break, investigator B will take a second set of 3 images (set C) Intra-rater agreement will be assessed by comparing mean and standard deviation of both set A and C, and calculating the intra-class correlation co-efficient for agreement.
Day 1
Intra-rater agreement, echogenicity of the geniohyoid muscle, sagittal plane
時間枠:Day 1
Investigator A will have taken 2 sets of 3 images (sets A and B) of the geniohyoid muscle in the sagittal plane. Echogenicity will be measured offline using appropriate imaging software (Image J, NIH) and compared by mean and standard deviation, and by intra-class correlation coefficient for consistency.
Day 1
Inter-rater agreement, echogenicity of the geniohyoid muscle, sagittal plane
時間枠:Day 1
Investigator A will have taken 2 sets of 3 images (sets A and B) of the geniohyoid muscle in the sagittal plane, and investigator B will take set of 3 images (set C). Echogenicity will be measured offline using appropriate imaging software (Image J, NIH) and compared by mean and standard deviation, and by intra-class correlation coefficient for absolute agreement.
Day 1

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (推定)

2026年6月1日

一次修了 (推定)

2027年1月1日

研究の完了 (推定)

2027年6月1日

試験登録日

最初に提出

2026年5月18日

QC基準を満たした最初の提出物

2026年5月18日

最初の投稿 (実際)

2026年5月26日

学習記録の更新

投稿された最後の更新 (実際)

2026年5月28日

QC基準を満たした最後の更新が送信されました

2026年5月22日

最終確認日

2026年5月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • W0001
  • 26/NW/0011 (その他の識別子:REC - North West Greater Manchester South)

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

はい

IPD プランの説明

All IPD that underlie results in a publication will be made available upon reasonable request.

IPD 共有時間枠

At any point after the cessation of the study.

IPD 共有アクセス基準

Anonymised baseline data (age, weight, height etc), and their associated measured (geniohyoid muscle cross sectional areas and echogenicities) and associated results and summary/inferential statistics will be made available on request to the corresponding author of any future publication.

IPD 共有サポート情報タイプ

  • STUDY_PROTOCOL
  • ICF

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する